Show simple item record

dc.contributor.authorWright, H. L.*
dc.contributor.authorMcCarthy, Helen S.*
dc.contributor.authorMiddleton, Jim F.*
dc.contributor.authorMarshall, Michael J.*
dc.date.accessioned2011-12-16T17:07:40Z
dc.date.available2011-12-16T17:07:40Z
dc.date.issued2008-12-20
dc.identifier.citationCurrent Reviews in Musculoskeletal Medicine, 2009, 2(1), pp. 56-64
dc.identifier.issn1935-973Xen
dc.identifier.issn1935-9748en
dc.identifier.doi10.1007/s12178-009-9046-7
dc.identifier.urihttp://hdl.handle.net/10034/197718
dc.descriptionThis article is not available through ChesterRep.
dc.description.abstractThis review discusses the latest news and views on the mechanisms controlling bone resorption in normal and pathological conditions.
dc.language.isoenen
dc.relation.urlhttp://www.springerlink.com/index/10.1007/s12178-009-9046-7en
dc.subjectosteoprotegerin (OPG)en
dc.subjectreceptor activator of nuclear factor kappa beta (RANK)en
dc.subjectreceptor activator of nuclear factor kappa beta ligand (RANKL)en
dc.subjectbone diseaseen
dc.titleRANK, RANKL and osteoprotegerin in bone biology and diseaseen
dc.typeArticle
dc.contributor.departmentCharles Salt Centre, Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Trust in Oswestry
dc.identifier.journalCurrent Reviews in Musculoskeletal Medicineen
dc.date.accepted2018-11-25
html.description.abstractThis review discusses the latest news and views on the mechanisms controlling bone resorption in normal and pathological conditions.


This item appears in the following Collection(s)

Show simple item record